In the clinic for July 20, 2026
AI Briefing
- GSK announces positive data for new cancer treatment.
- Inflammasome's experimental therapy shows promising results in trials.
- Iveena's medical device receives FDA clearance for new use.
Source Summary
Clinical updates for biopharma and med tech, including data readouts and publications: GSK, Inflammasome, Iveena, Takeda.
Advertisement